Status:
UNKNOWN
IGFBP-3 in Ovarian Cancer Invasion
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Ovarian Carcinoma
Eligibility:
FEMALE
21-80 years
Phase:
NA
Brief Summary
An ovarian cancer cell line (OVTW-59) derived from an ovarian endometrioid carcinoma was established and its sublines, labeled as P0, P1, P2, P3, and P4 with increasing invasion abilities were selecte...
Detailed Description
We have successfully established an ovarian cancer cell line (OVTW-59), which was derived from an ovarian endometrioid carcinoma. Its sublines, labeled as P0, P1, P2, P3, and P4 with increasing invasi...
Eligibility Criteria
Inclusion
- Ovarian Endometrioid Adenocarcinoma
Exclusion
- Other types of ovaria epithelial cell carcinoma
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00154986
Start Date
August 1 2004
End Date
July 1 2005
Last Update
September 12 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwna University Hospital
Taipei, Taiwan, 10020